Meet Companies Launched by CTV
CWRU Technology Ventures invests in early-stage companies based on technology developed at CWRU and our affiliate institutions. We believe that by providing critical funding at the early stages of a company's growth, that we can increase its chances of becoming a commercial success. CTV is always evaluating new opportunities, so check back often and watch our portfolio grow.
Synapse Biomedical Inc.
Synapse Biomedical Inc (SBI) was founded in September 2002 to commercialize the NeuRx Diaphragm Pacing System (DPS)® that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.
Neuros Medical, a Cleveland, Ohio based neuromodulation company, is focused on developing proprietary therapies for unmet needs to patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post surgical pain, and chronic migraine.
Great Lakes Pharmaceuticals
Great Lakes Pharmaceuticals, Inc. is a clinical stage company focused on developing and commercializing products that prevent infections associated with indwelling catheters.
Intwine Connect is an independent company committed to developing hardware, software, and IoT services for the monitoring and management of business- critical performance data.
CardioInsight is a Cleveland, Ohio based medical device company that has developed a unique, non-invasive advanced cardiac mapping technology to map electrical disorders of the heart. The technology combines body surface electrical data with with heart and torso anatomy to provide single beat epicardial 3D electroanatomic maps of the heart.